Profiel
Paul Dick is currently a Partner at Vet Venture Capital, Inc. He was previously the Chief Executive Officer & Director at Avivagen, Inc. from 2008 to 2010.
He also served as a Director at AbCelex Technologies, Inc. Dr. Dick holds a doctorate degree from the University of Guelph.
Actieve functies van Paul Dick
| Bedrijven | Functie | Begin |
|---|---|---|
Vet Venture Capital, Inc.
Vet Venture Capital, Inc. Investment ManagersFinance Vet Venture Capital invests in companies operating in the fields of food & companion animal health markets that develop pharmaceuticals, vaccines, diagnostics, science-based wellness products and drug delivery mechanisms. The firm initially invests in the range of $100K to $5 million and also participates in the follow-on rounds of investments. It acts as a lead investor, along with con-investments and takes both minority & majority interests, also seeks board seat requirement. | Private Equity Investor | - |
Eerdere bekende functies van Paul Dick
| Bedrijven | Functie | Einde |
|---|---|---|
| AVIVAGEN INC. | President | 01-10-2010 |
AbCelex Technologies, Inc.
AbCelex Technologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Bestuurslid | - |
Opleiding van Paul Dick
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Guelph
University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avivagen, Inc.
Avivagen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes health supplements for animals & pets | Commercial Services |
Vet Venture Capital, Inc.
Vet Venture Capital, Inc. Investment ManagersFinance Vet Venture Capital invests in companies operating in the fields of food & companion animal health markets that develop pharmaceuticals, vaccines, diagnostics, science-based wellness products and drug delivery mechanisms. The firm initially invests in the range of $100K to $5 million and also participates in the follow-on rounds of investments. It acts as a lead investor, along with con-investments and takes both minority & majority interests, also seeks board seat requirement. | Finance |
AbCelex Technologies, Inc.
AbCelex Technologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
















